In this minisode, Mindy, Ryan, and Jen discuss a few recent newsworthy items including: our top headlines from the JP Morgan Healthcare Conference (00:32) and the preliminary national coverage decision for Aduhelm from CMS (14:29).
Podcast Tags: healthcare, healthcare news, healthcare workforce, gene therapy, whole person health, Medicare Advantage, CMS, Alzheimer’s
Source Links:
· https://www.bloomberg.com/news/articles/2022-01-12/rna-is-hot-but-mergers-are-not
· https://www.modernhealthcare.com/finance/jp-morgans-2022-health-conference
· https://www.cms.gov/medicare-coverage-database/view/ncacal-decision-memo
· https://www.kff.org/policy-watch/medicares-coverage-decision-for-the-new-alzheimers-drug
· https://www.managedhealthcareexecutive.com/view/5-things-you-should-know
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
Mindy McGrath, Healthcare Industry Advisor
Ryan Hummel, Executive and Head of Provider Sector
Jen Burke, Healthcare Industry Strategist
13 January 2022
Inizio’s Global Director of Inclusion and Impact, Naseem Ahmed, has been appointed as a judge for the BPLS Inspire Awards.
Read moreIn the last three years, Generative AI (GenAI) has moved from novelty to expectation. Across industries, teams are being asked, whether explicitly or
Read moreInizio Ignite brings together Research Partnership, Putnam, Vynamic, and STEM.
Read more